Gilder Gagnon Howe & Co’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
ACH
FLAM
EWM
Gilder Gagnon Howe & Co's AXGN Position: Q4 2020 in Review
Gilder Gagnon Howe & Co sold out of Axogen (AXGN) in Q4 2020, closing a stake of 24,713 shares — an estimated $287K sold.
Gilder Gagnon Howe & Co first reported a position in AXGN in Q4 2016 and held it in 16 quarters. The position peaked at $30M in Q2 2018. 121 funds tracked by Wall St. Rank hold AXGN as of Q4 2020.
- Gilder Gagnon Howe & Co reported no remaining Axogen position as of Q4 2020 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 24,713 Axogen shares in Q4 2020, an estimated $287K.
- Gilder Gagnon Howe & Co first reported a position in Axogen in Q4 2016 and held it in 16 quarters.
- Gilder Gagnon Howe & Co's Axogen position peaked at $30M in Q2 2018.
- 121 funds tracked by Wall St. Rank held Axogen as of Q4 2020.
Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.